2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
High Dose Eylea for Proliferative Diabetic Retinopathy OutcomesProliferative Diabetic Retinopathy (PDR)Active, not recruitingPhase 42026-03-18NCT07118670
Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)Neovascular (Wet) AMDActive, not recruitingPhase 1 / Phase 22026-02-12NCT06550011